Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

CANC

Tema Oncology ETF

Nov 21 • 04:00PM ET

34.49

+0.47 1.38 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	31.40%	Total Holdings	54	Perf Week	3.92%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	96.33M	Perf Month	15.82%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	30.92%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	34.53 -0.11%	Perf Half Y	42.17%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 71.63%	Perf YTD	41.89%
Active/Passive		Quant Type		Tags	-	Flows% 1M	2.44%	Volatility	2.10% 1.83%	Perf Year	32.87%
Dividend TTM	0.50 (1.45%)	ESG Type		Tags	-	Flows% 3M	7.31%	ATR (14)	0.66	Perf 3Y	-
Dividend Ex-Date	Dec 11, 2024	Dividend Type		Sector/Theme		Flows% YTD	32.22%	RSI (14)	79.89	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.79	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	7.62%	Flows% 3Y		Rel Volume	12.04	Prev Close	34.02
Inverse/Leveraged		Market Cap		SMA50	14.43%	Flows% 5Y		Avg Volume	9.82K	Price	34.49
IPO	Aug 16, 2023	Option/Short	No / No	SMA200	30.80%	Trades		Volume	118,182	Change	1.38%

Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

Black Swan Sale

50% Off Elite

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience